Cancer irradiation systems installed in Ethiopia for the first time

2014-08-04 Page Views : 614 Author : Admin

Important Notes:

In January 2021, BEBIG Medical GmbH took over the global production and distribution structures of the HDR brachytherapy products of Eckert & Ziegler BEBIG GmbH including Mick Radio-Nuclear Instruments, Inc.

Below news are related to the HDR brachytherapy business and is quoted originally from the website:


Original Content:

For the first time, a system designed to provide radiation in treating gynecological tumors with brachytherapy sources has been installed in a hospital in Addis Ababa, the capital of Ethiopia, as part of a United Nations aid program for expanding healthcare in Africa. Brachytherapy involves miniaturized, wire-guided radiation sources placed at the site of the tumor, which are especially effective in treating cervical cancer. The GyneSource afterloader was provided by Berlin-based Eckert & Ziegler BEBIG GmbH and was successfully put into operation last month. 

Tikur Anbessa (Black Lion) Hospital, one of the largest hospitals in Addis Ababa, was the recipient. It owns the country’s only specialized cancer center and recently began expanding its treatment options with the new afterloader. According to information provided by Ethiopia’s Ministry of Health, there are more than 150,000 cancer cases per year in the country. There have been very few options for treating cancer patients until now. 

GyneSource is a multichannel HDR afterloader especially developed for treating gynecological tumors quickly and cost-effectively. It is operated using cobalt radiation sources known for their long service life, which increases cost efficiency. BEBIG is one of the few providers of such equipment, which has helped it to secure success in the healthcare sector of emerging economies. The company works together with United Nations organizations and the World Bank.


About BEBIG Medical GmbH:

BEBIG Medical GmbH (“BEBIG Medical”) is a global provider of high quality radiation therapy products for cancer treatment headquartered in Berlin, Germany. Preceded by the high dose brachytherapy business unit of Eckert & Ziegler AG, BEBIG Medical has a heritage of more than 40 years’ experience in brachytherapy field and continues to provide affordable healthcare with proven clinical outcomes via strong and viable technology.BEBIG Medical’s US subsidiary, Mick Radio-Nuclear Instruments, Inc., is also known internationally for its manufacturing expertise in the field of applicators and accessories to advance brachytherapy. With a team of professionals and offices in Europe, United States and Asia, the company is empowered to serve customers in more than 65 countries and regions together with a worldwide distribution network.



Crystal Chen, Chief Commercial Officer:

Related News
+49 30 9487888-10
Robert-Rössle-Str. 10, 13125 Berlin Germany

Copyright © BEBIG Medical. All rights reserved.